Italian researchers have found that Lexapro and Zoloft are the best of 12 new-generation antidepressants, while reboxetine (sold as Vestra and Edronax) is the least effective. In the study, scientists tested a wide range of new antidepressants and found that Zoloft and Lexapro were the best in terms of effectiveness and patient acceptability. Two other new antidepressants--Remeron and Effexor--were as effective the two best drugs, but more patients stopped taking these than Zoloft and Lexapro.
Read moreOut with the old, in with the new; the world seems to revolve around this constant turnover. Sometimes new technology has a huge advantage,... Read more »
A New England Journal of Medicine study reviewed numerous antidepressant trials up to 2004, in an attempt to determine how well the data... Read more »
My last post looked into the benefit of some drugs with an anti-depressant effect in the treatment of the chronic pain of fibromyalgia. ... Read more »
Almost everyone who takes antidepressants gains at least 15 pounds. Add mood stabilizers to the mix of medications and weight can shoot up... Read more »
I had my quarterly appointment with my psychiatrist the other day. As planned, I told him that I would like to switch to a new... Read more »
A new antidepressant, vilazodone, treats depression symptoms while also preserving patients' sex drive, a new study has shown. In the recent clinical... Read more »
A new antidepressant has shown mixed results in new clinical trials. Drugmaker Targacept reported that its new treatment for acute depression,... Read more »
A new depression treatment called Tyrima has entered clinical trials. The new antidepressant is in a class of medicines known as reversible... Read more »
Selective serotonin-reuptake inhibitors (SSRIs) such as Paxil, Prozac, and Zoloft have been the darlings of the antidepressant market for years. New... Read more »
Drugmaker Wyeth has reported that the launch of its new experimental antidepressant, DVS-233, has been moved to 2007 following reports of nausea in... Read more »